✦ LIBER ✦

Is prolonged use of corticosteroids safe in patients with Crohn's disease?

✍ Scribed by Dr. Meryl S. Leboff

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 483 KB
Volume: 3
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.3780030212

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is the prolonged use of low-dose steroid

Is the prolonged use of low-dose steroids safe for Crohn's disease?

✍ Peter A. Banks; Daniel H. Present 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Is ect safe in patients with cerebrovasc

Is ect safe in patients with cerebrovascular disease?

✍ Patricia Anna Blackburn; Peter Decalmer 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 1 views

## Abstract A 70‐year‐old man with a history of peripheral vascular disease was treated initially with antidepressants, then bilateral electroconvulsive therapy (ECT) for a depressive illness. Apart from an episode of delirium following ECT he recovered fully. Four years later he relapsed. Low‐dose

EBV hepatitis in a young Crohn's disease

EBV hepatitis in a young Crohn's disease patient on prolonged remission with azathioprine

✍ E. Angelucci; M. Cesarini; E. Caturelli; P. Vernia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

Sarcopenia is prevalent in patients with

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission

✍ Stéphane M. Schneider; Rima Al-Jaouni; Jerôme Filippi; Jean-Baptiste Wiroth; Gil 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

## Background: Patients with Crohn's disease (CD) are prone to osteoporosis. A loss of muscle mass, called sarcopenia, is responsible for an increased risk of disability. Many factors associated with osteopenia also decrease muscle mass. The aim of the present study was to measure the prevalence o

Further experience with the use of 6-thi

Further experience with the use of 6-thioguanine in patients with Crohn's disease

✍ Azhar Ansari; Tim Elliott; Farina Fong; Monica Arenas-Hernandez; Giles Rottenber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Background: 6-Thioguanine (6-TG) is efficacious in patients with Crohn's Disease (CD) failing conventional immunosuppression but there are reports of hepatotoxicity. We report our experience of the safety and efficacy of 6-TG in a series of patients with CD. Methods: A retrospective study of patien

Immediate and long-term outcomes of cort

Immediate and long-term outcomes of corticosteroid therapy in pediatric crohn's disease patients

✍ Alfreda Krupoves; David R. Mack; Ernest G. Seidman; Colette Deslandres; Vytautas 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

Background: Although a mainstay of treatment of moderate to severe Crohn's disease (CD), corticosteroids use presents significant challenges because of large interindividual variability in response. Corticosteroid-dependence is of particular concern in children, where high rates have been reported.